title: Pregnancy outcome following exposure to orlistat, ramipril, glimepiride in a woman with metabolic syndrome.
authors.affiliation: Department of Pharmacology, Karadeniz Technical University, School of Medicine, Trabzon, Turkey.
authors.forename: Nuri I
authors.initials: NI
authors.lastname: Kalyoncu
authors.forename: Fusun
authors.initials: F
authors.lastname: Yaris
authors.forename: Mine
authors.initials: M
authors.lastname: Kadioglu
authors.forename: Murat
authors.initials: M
authors.lastname: Kesim
authors.forename: Cunay
authors.initials: C
authors.lastname: Ulku
authors.forename: Ersin
authors.initials: E
authors.lastname: Yaris
authors.forename: Mesut
authors.initials: M
authors.lastname: Unsal
authors.forename: Mustafa
authors.initials: M
authors.lastname: Dikici
mesh_terms: D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007783:Lactones / Q000627:therapeutic use; D024821:Metabolic Syndrome / Q000188:drug therapy*; D000077403:Orlistat; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011256:Pregnancy Outcome; D017257:Ramipril / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000627:therapeutic use
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D019440:Anti-Obesity Agents; D007004:Hypoglycemic Agents; D007783:Lactones; D013453:Sulfonylurea Compounds; C057619:glimepiride; D000077403:Orlistat; D017257:Ramipril